Your search returned 11 results.

Results
	1.	Reactions of benzene oxide, a reactive metabolite of benzene, with model nucleophiles and DNA. [electronic resource] by Míčová, Kateřina Linhart, Igor Producer: 20130625 In: Xenobiotica; the fate of foreign compounds in biological systems vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Flow injection analysis vs. ultra high performance liquid chromatography coupled with tandem mass spectrometry for determination of imatinib in human plasma. [electronic resource] by Mičová, Kateřina Friedecký, David Faber, Edgar Polýnková, Adriana Adam, Tomáš Producer: 20110119 In: Clinica chimica acta; international journal of clinical chemistry vol. 411 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Detailed study of imatinib metabolization using high-resolution mass spectrometry. [electronic resource] by Friedecký, David Mičová, Kateřina Faber, Edgar Hrdá, Marcela Široká, Jitka Adam, Tomáš Producer: 20151201 In: Journal of chromatography. A vol. 1409 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Novel sulphur-containing imatinib metabolites found by untargeted LC-HRMS analysis. [electronic resource] by Vrobel, Ivo Friedecký, David Faber, Edgar Najdekr, Lukáš Mičová, Kateřina Karlíková, Radana Adam, Tomáš Producer: 20180403 In: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences vol. 104 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Ultrafast Online SPE-MS/MS Method for Quantification of 3 Tyrosine Kinase Inhibitors in Human Plasma. [electronic resource] by Vrobel, Ivo Janečková, Hana Faber, Edgar Bouchalová, Kateřina Mičová, Kateřina Friedecký, David Adam, Tomáš Producer: 20171129 In: Therapeutic drug monitoring vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Dr Jekyll and Mr Hyde: a strange case of 5-ethynyl-2'-deoxyuridine and 5-ethynyl-2'-deoxycytidine. [electronic resource] by Ligasová, Anna Liboska, Radek Friedecký, David Mičová, Kateřina Adam, Tomáš Oždian, Tomáš Rosenberg, Ivan Koberna, Karel Producer: 20161007 In: Open biology vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Imatinib trough plasma levels do not correlate with the response to therapy in patients with chronic myeloid leukemia in routine clinical setting. [electronic resource] by Faber, Edgar Friedecký, David Mičová, Kateřina Rožmanová, Sárka Divoká, Martina Jarošová, Marie Indrák, Karel Adam, Tomáš Producer: 20120629 In: Annals of hematology vol. 91 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Metabolic status of CSF distinguishes rats with tauopathy from controls. [electronic resource] by Karlíková, Radana Mičová, Kateřina Najdekr, Lukáš Gardlo, Alžběta Adam, Tomáš Majerová, Petra Friedecký, David Kováč, Andrej Producer: 20180517 In: Alzheimer's research & therapy vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Imatinib dose escalation in two patients with chronic myeloid leukemia, with low trough imatinib plasma levels measured at various intervals from the beginning of therapy and with suboptimal treatment response, leads to the achievement of higher plasma levels and major molecular response. [electronic resource] by Faber, Edgar Friedecký, David Micová, Katerina Divoká, Martina Katrincsáková, Beata Rozmanová, Sárka Jarosová, Marie Indrák, Karel Adam, Tomás Producer: 20100927 In: International journal of hematology vol. 91 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	A lower dosage of imatinib is sufficient to maintain undetectable disease in patients with chronic myeloid leukemia with long-term low-grade toxicity of the treatment. [electronic resource] by Faber, Edgar Divoká, Martina Skoumalová, Ivana Novák, Martin Marešová, Ivana Mičová, Kateřina Friedecký, David Adam, Tomáš Jarošová, Marie Indrák, Karel Publication details: Leukemia & lymphoma Feb 2016 In: Leukemia & lymphoma vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Metabolite Profiling of the Plasma and Leukocytes of Chronic Myeloid Leukemia Patients. [electronic resource] by Karlíková, Radana Široká, Jitka Friedecký, David Faber, Edgar Hrdá, Marcela Mičová, Kateřina Fikarová, Iveta Gardlo, Alžběta Janečková, Hana Vrobel, Ivo Adam, Tomáš Producer: 20171106 In: Journal of proteome research vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)